Under the terms of the proposed transaction, Oracle will acquire Acme for approximately $29.25 per share, representing a total deal value of approximately $2.1 billion. The offer price is below at least one analyst's price target of $30 per share. Indeed, one of the most recent analyst updates regarding Acme securities was by the highly regarded brokerage firm Northland Securities, which upgraded the stock from market perform to outperform just two weeks prior to the transaction announcement. Similarly, the analysts of Stifel Nicolaus and Mizuho also have upgraded their recommendation of the stock in 2013. The Company's share price has increased approximately 32% between November 2012 and January 2013, and the stock was likely to continue its growth well beyond the offer price. Currently, shareholders will collect a paltry 18% premium on the previous day's closing price. The transaction appears purposely timed to take advantage of a temporary dip in the Company's stock price, as it traded above $30 per share as recently as May, 2012. As such, it appears that the proposed offer price provides an insufficient premium to shareholders
I guess some lawyers wonder as well. You have to wonder why sell now. ACME could easily of
gotten more for shareholders unless of course Sonus is starting to beat them on deals and Ory said enough..